<DOC>
	<DOC>NCT00683410</DOC>
	<brief_summary>To collect post-marketing information on the safety of Prevenar in Filipino patients</brief_summary>
	<brief_title>Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>All patients from the study center who received or will receive at least one dose of Prevenar according to the approved product indication. Previously discontinued Prevenar therapy due to safety concerns.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>